What Pharma Can Learn From Military Intelligence
Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence
Clinical Scorecard: What Pharma Can Learn From Military Intelligence
At a Glance
Category Detail
Condition Market Intelligence in Pharma Key Mechanisms Proactive intelligence management, decision cycle optimization, actionable insights Target Population Pharmaceutical and biotech companies Care Setting Pharmaceutical industry
Key Highlights
Intelligence processes must support organizational strategy and tactics. Early warning intelligence is crucial to avoid being blindsided. Pharma companies often lack a structured approach to intelligence. AI should be purpose-built to address specific problems in intelligence gathering. Decision cycle time is critical for adapting strategies in a dynamic environment. Guideline-Based Recommendations
Diagnosis
Identify key environmental signals and monitor them proactively. Management
Integrate intelligence into planning and execution processes. Monitoring & Follow-up
Establish contingency plans tied to monitored signals. Risks
Failure to adapt can lead to crisis reaction mode. Patient & Prescribing Data
Not applicable; focuses on organizational intelligence processes.
Emphasizes the need for actionable and trustworthy information.
Clinical Best Practices
Organize intelligence as a distinct management process. Utilize frameworks and tools for effective intelligence gathering. Ensure intelligence is integrated into decision-making cycles. Related Resources & Content
